TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study

Abstract Introduction This prospective study aimed to determine whether trimetazidine (TMZ) alters the pharmacodynamic (PD) effects of clopidogrel. Methods Patients with stable coronary artery disease (SCAD) (n = 24) who were actively treated with dual antiplatelet therapy (DAPT) of aspirin 81 mg da...

Full description

Bibliographic Details
Main Authors: Naveen Seecheran, Victoria Seebalack, Rajeev Seecheran, Aarti Maharaj, Brent Boodhai, Valmiki Seecheran, Sangeeta Persad, Shastri Motilal, Antonio Tello-Montoliu, David Schneider
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-07-01
Series:Cardiology and Therapy
Subjects:
Clopidogrel
Platelet reactivity
Trimetazidine
Online Access:http://link.springer.com/article/10.1007/s40119-019-0139-0

Internet

http://link.springer.com/article/10.1007/s40119-019-0139-0

Similar Items